The FDA has approved an oral tablet formulation of sodium sulfate, magnesium sulfate, and potassium chloride (Sutab – Braintree) for colon cleansing prior to colonoscopy in adults. A sodium sulfate-based oral solution (Suprep) has been available in the US since 2010. Sutab is the second tablet formulation to be approved for bowel cleansing prior to colonoscopy; a sodium phosphate-based tablet (OsmoPrep) was approved earlier.

COLONOSCOPY PREPARATIONS — Traditional polyethylene glycol (PEG) plus electrolytes solutions for bowel cleansing prior to colonoscopy are isotonic and require patients to ingest up to 4 L of fluid to produce a cathartic effect....  Continue reading

More from Issue 1619
Previous Issue: 1618      February 22, 2021
Coming Soon
Low-Dose Colchicine for Coronary Artery Disease
Drugs for Multiple Sclerosis
Semaglutide (Ozempic) for Weight Loss
In Brief: Hypertension with Erenumab (Aimovig)
Follow us   Twitter LinkedIn YouTube Blog RSS   Email Alerts
Advance Release

On February 27, 2021, the FDA issued an Emergency Use Authorization (EUA) for the Johnson & Johnson adenovirus-based vaccine for prevention of COVID-19 in persons ≥18 years old. It is the third COVID-19 vaccine to become available in the US and the first to require only a single dose. Two-dose mRNA-based vaccines manufactured by Pfizer-BioNTech and Moderna received EUAs in December ... Continue reading